0001192482-18-000051.txt : 20180122 0001192482-18-000051.hdr.sgml : 20180122 20180122170701 ACCESSION NUMBER: 0001192482-18-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180118 FILED AS OF DATE: 20180122 DATE AS OF CHANGE: 20180122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCallum Stewart CENTRAL INDEX KEY: 0001659872 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 18540455 MAIL ADDRESS: STREET 1: C/O RECRO PHARMA, INC. STREET 2: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-01-18 0001588972 Recro Pharma, Inc. REPH 0001659872 McCallum Stewart C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Chief Medical Officer Common Stock 2018-01-18 4 M 0 6000 A 33701 D Common Stock 2018-01-18 4 F 0 1860 8.89 D 31841 D Restricted Stock Units 2018-01-18 4 M 0 6000 0 D Common Stock 6000 18000 D Restricted stock units convert into common stock on a one-for-one basis. On January 18, 2017, the reporting person was granted 24,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. /s/ Ryan D. Lake, Attorney-in-fact 2018-01-22